33 research outputs found
Diferenciación craniométrica de las especies de corzuelas pardas de Brasil
The genus Mazama (brocket deer) constitutes successful adaptive radiation, with a wide distribution in the Neotropical region. However, the taxonomy and systematics of its species and subspecies is still controversial. The objective of this contribution was to carry out a comparative craniometric study of specimens deposited in Brazilian museums of M. gouazoubira (Mg) and M. nemorivaga (Mn), in order to characterize these cryptic species. We performed 36 measures on 87 skulls of adult specimens (Mg = 32 females and 27 males; Mn = 14 females and 14 males). The sample was compared by analysis of variance and multivariate analysis of principal components and discriminant. In most cranial measurements, males and females of M. gouazoubira were 5% larger, with the exception of 3 measures: premolar-prosthion, basifacial axis, and least breadth between the orbits, that were larger in males and females of M. nemorivaga. This study showed significant differences between the two taxa that would validate the distinction of both species. To examine in more detail the dynamics of the variation of these two taxa it is necessary to increase the sample size in order to analyse them in a geographical and genetic context.El género Mazama constituye una exitosa radiación adaptativa, con una amplia distribución en la región Neotropical. Sin embargo, la taxonomía y sistemática sus especies y subespecies es todavía motivo de controversias. El objetivo de esta contribución fue realizar un estudio craneométrico comparativo de ejemplares depositados en museos de Brasil de M. gouazoubira (Mg) y M. nemorivaga (Mn), con el fin de caracterizar estas especies cripticas. Se tomaron 36 medidas en 87 cráneos de ejemplares adultos (Mg = 32 hembras y 27 machos; Mn = 14 hembras y 14 machos). La muestra se comparó mediante análisis de la varianza y análisis multivariados de componentes princi¬pales y discriminante. En la mayoría de las medidas craneanas los ejemplares machos y hembras de M. gouazou¬bira fueron un 5% más grandes, con la excepción de 3 medidas: premolar - prosthion, eje basifacial y el ancho menor entre orbitas, que presentaron mayor tamaño en los ejemplares machos y hembras de M. nemorivaga. Este estudio permitió mostrar que existen diferencias significativas entre los dos taxa, que validarían la distinción de ambas especies. Para examinar con más detalle la dinámica de la variación de estos dos taxa es necesario aumentar el tamaño de las muestras y analizarlas en un contexto geográfico y genético
Comparison of three models of population density estimation for Central American red brocket deer (Mazama temama)
The deer Mazama temama has a wide range in the tropical rain forest of Mexico, but the IUCN classifies it as Data Deficient, and information is urgently need for management and conservation. Here we assess which population density estimation model is more appropriate among those by Tyson (1959), Mandujano and Jones (2005) and Crego and Macri (2009). We compare them with field data from Tepetla (Puebla, Mexico), from 2015 to 2017, with three replicates in the wet season and three in dry season. An ANOVA indicated that the three
methods produce equivalent results
Maned wolves retain moderate levels of genetic diversity and gene flow despite drastic habitat fragmentation
The maned wolf Chrysocyon brachyurus is the largest South American canid and categorized as Near Threatened on the IUCN Red List. The major threat to conservation efforts is the drastic reduction of suitable habitat for the species. A large portion of its range has been converted into farm and ranch lands as well as urban areas. To better understand the impact that these anthropogenic activities are having over the remaining populations across their current distribution range, we evaluated patterns of genetic variability and differentiation between them. We also compared these results with those obtained from captive maned wolves in order to make proper ex situ recommendations. We cross-amplified 12 microsatellite loci in maned wolf samples
collected throughout their range (from Argentina, Brazil, Uruguay and Bolivia) and from captive stocks (from captive breeding centers and zoos in Brazil, Argentina and the USA). We found that wild populations retain moderate levels of genetic variability compared with other microsatellite studies on wild canids, and our structure analysis revealed 2 genetic clusters in wild samples, one of which included samples exclusively from Bolivia. This cluster could represent a different management unit with conservation priority. The captive stock population showed higher levels of genetic variability, with the ones from Brazil being the most genetically diverse stock. The USA stock showed strong genetic differences with all other groups. This is the first study to examine
the patterns of genetic diversity of both wild and captive populations of maned wolves. These results should be incorporated into further population viability assessments and in the Maned Wolf Species Survival Plan
Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022
During June 2022, Spain was one of the countries most affected worldwide by a multicountry monkeypox outbreak with chains of transmission without identified links to disease-endemic countries. We provide epidemiologic features of cases reported in Spain and the coordinated measures taken to respond to this outbreak.S
Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases
Altres ajuts: Generalitat de Catalunya, Departament de Salut; Generalitat de Catalunya, Departament d'Empresa i Coneixement i CERCA Program; Ministerio de Ciencia e Innovación; Instituto Nacional de Bioinformática; ELIXIR Implementation Studies (CNAG-CRG); Centro de Investigaciones Biomédicas en Red de Enfermedades Raras; Centro de Excelencia Severo Ochoa; European Regional Development Fund (FEDER).Many patients experiencing a rare disease remain undiagnosed even after genomic testing. Reanalysis of existing genomic data has shown to increase diagnostic yield, although there are few systematic and comprehensive reanalysis efforts that enable collaborative interpretation and future reinterpretation. The Undiagnosed Rare Disease Program of Catalonia project collated previously inconclusive good quality genomic data (panels, exomes, and genomes) and standardized phenotypic profiles from 323 families (543 individuals) with a neurologic rare disease. The data were reanalyzed systematically to identify relatedness, runs of homozygosity, consanguinity, single-nucleotide variants, insertions and deletions, and copy number variants. Data were shared and collaboratively interpreted within the consortium through a customized Genome-Phenome Analysis Platform, which also enables future data reinterpretation. Reanalysis of existing genomic data provided a diagnosis for 20.7% of the patients, including 1.8% diagnosed after the generation of additional genomic data to identify a second pathogenic heterozygous variant. Diagnostic rate was significantly higher for family-based exome/genome reanalysis compared with singleton panels. Most new diagnoses were attributable to recent gene-disease associations (50.8%), additional or improved bioinformatic analysis (19.7%), and standardized phenotyping data integrated within the Undiagnosed Rare Disease Program of Catalonia Genome-Phenome Analysis Platform functionalities (18%)
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.
Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may suffer from this complication. CDA is a complex trait with a polygenic component that is mainly unidentified. We propose that levels of intermediate molecular phenotypes (IMPs) in the myocardium associated with histopathological damage could explain CDA susceptibility, so variants of genes encoding these IMPs could identify patients susceptible to this complication. Thus, a genetically heterogeneous cohort of mice (n = 165) generated by backcrossing were treated with doxorubicin and docetaxel. We quantified heart fibrosis using an Ariol slide scanner and intramyocardial levels of IMPs using multiplex bead arrays and QPCR. We identified quantitative trait loci linked to IMPs (ipQTLs) and cdaQTLs via linkage analysis. In three cancer patient cohorts, CDA was quantified using echocardiography or Cardiac Magnetic Resonance. CDA behaves as a complex trait in the mouse cohort. IMP levels in the myocardium were associated with CDA. ipQTLs integrated into genetic models with cdaQTLs account for more CDA phenotypic variation than that explained by cda-QTLs alone. Allelic forms of genes encoding IMPs associated with CDA in mice, including AKT1, MAPK14, MAPK8, STAT3, CAS3, and TP53, are genetic determinants of CDA in patients. Two genetic risk scores for pediatric patients (n = 71) and women with breast cancer (n = 420) were generated using machine-learning Least Absolute Shrinkage and Selection Operator (LASSO) regression. Thus, IMPs associated with heart damage identify genetic markers of CDA risk, thereby allowing more personalized patient management.J.P.L.’s lab is sponsored by Grant PID2020-118527RB-I00 funded by MCIN/AEI/10.13039/
501100011039; Grant PDC2021-121735-I00 funded by MCIN/AEI/10.13039/501100011039 and by
the “European Union Next Generation EU/PRTR”, the Regional Government of Castile and León
(CSI144P20). J.P.L. and P.L.S. are supported by the Carlos III Health Institute (PIE14/00066). AGN
laboratory and human patients’ studies are supported by an ISCIII project grant (PI18/01242). The
Human Genotyping unit is a member of CeGen, PRB3, and is supported by grant PT17/0019 of the
PE I + D + i 2013–2016, funded by ISCIII and ERDF. SCLl is supported by MINECO/FEDER research
grants (RTI2018-094130-B-100). CH was supported by the Department of Defense (DoD) BCRP,
No. BC190820; and the National Cancer Institute (NCI) at the National Institutes of Health (NIH),
No. R01CA184476. Lawrence Berkeley National Laboratory (LBNL) is a multi-program national
laboratory operated by the University of California for the DOE under contract DE AC02-05CH11231.
The Proteomics Unit belongs to ProteoRed, PRB3-ISCIII, supported by grant PT17/0019/0023 of
the PE I + D +i, 2017–2020, funded by ISCIII and FEDER. RCC is funded by fellowships from
the Spanish Regional Government of Castile and León. NGS is a recipient of an FPU fellowship
(MINECO/FEDER). hiPSC-CM studies were funded in part by the “la Caixa” Banking Foundation
under the project code HR18-00304 and a Severo Ochoa CNIC Intramural Project (Exp. 12-2016
IGP) to J.J.S
El reto de la inclusión de los Objetivos de Desarrollo Sostenible en la formación inicial de profesores de secundaria: creación del MOOC curso cero sobre educación y ODS, inclusión en asignaturas y en trabajos fin de máster
Memoria ID-041. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2021-2022
Clinical and Ecological Impact of an Educational Program to Optimize Antibiotic Treatments in Nursing Homes (PROA-SENIOR): A Cluster, Randomized, Controlled Trial and Interrupted Time-Series Analysis
[Background] Antimicrobial stewardship programs (ASPs) are recommended in nursing homes (NHs), although data are limited. We aimed to determine the clinical and ecological impact of an ASP for NHs.[Methods] We performed a cluster, randomized, controlled trial and a before–after study with interrupted time-series analyses in 14 NHs for 30 consecutive months from July 2018 to December 2020 in Andalusia, Spain. Seven facilities implemented an ASP with a bundle of 5 educational measures (general ASP) and 7 added 1-to-1 educational interviews (experimental ASP). The primary outcome was the overall use of antimicrobials, calculated monthly as defined daily doses (DDD) per 1000 resident days (DRD).[Results] The total mean antimicrobial consumption decreased by 31.2% (−16.72 DRD; P = .045) with respect to the preintervention period; the overall use of quinolones and amoxicillin–clavulanic acid dropped by 52.2% (P = .001) and 42.5% (P = .006), respectively; and the overall prevalence of multidrug-resistant organisms (MDROs) decreased from 24.7% to 17.4% (P = .012). During the intervention period, 12.5 educational interviews per doctor were performed in the experimental ASP group; no differences were found in the total mean antimicrobial use between groups (−14.62 DRD; P = .25). Two unexpected coronavirus disease 2019 waves affected the centers increasing the overall mean use of antimicrobials by 40% (51.56 DRD; P < .0001).[Conclusions] This study suggests that an ASP for NHs appears to be associated with a decrease in total consumption of antimicrobials and prevalence of MDROs. This trial did not find benefits associated with educational interviews, probably due to the coronavirus disease 2019 pandemic.[Clinical Trials Registration] NCT03543605.Peer reviewe
Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-alpha 2 in 10 patients: IFN-alpha 2 only in three, IFN-alpha 2 plus IFN-omega in five, and IFN-alpha 2, IFN-omega plus IFN-beta in two; IFN-omega only in nine patients). Seven children (3.8%) had Abs neutralizing at least 10 ng/ml of one IFN, whereas the other 12 (6.6%) had Abs neutralizing only 100 pg/ml. The auto-Abs neutralized both unglycosylated and glycosylated IFNs. We also detected auto-Abs neutralizing 100 pg/ml IFN-alpha 2 in 4 of 2,267 uninfected children (0.2%) and auto-Abs neutralizing IFN-omega in 45 children (2%). The odds ratios (ORs) for life-threatening COVID-19 pneumonia were, therefore, higher for auto-Abs neutralizing IFN-alpha 2 only (OR [95% CI] = 67.6 [5.7-9,196.6]) than for auto-Abs neutralizing IFN-. only (OR [95% CI] = 2.6 [1.2-5.3]). ORs were also higher for auto-Abs neutralizing high concentrations (OR [95% CI] = 12.9 [4.6-35.9]) than for those neutralizing low concentrations (OR [95% CI] = 5.5 [3.1-9.6]) of IFN-omega and/or IFN-alpha 2